It was reported that apelin regulates insulin sensitivity, stimulates glucose utilization and enhances brown adipogenesis in different tissues associated with diabetes 12, 41, indicating the apelin–APJ system as a novel therapeutic target for pharmacological intervention in treating diabetes. This evidence concerns the gene APLNR and diabetes mellitus.